AlphaStocks
1.3
Avoid

STAAR SURGICAL CO (STAA)

Health Care / Health Care Equipment

S&P SmallCap 600

$19.34

Scores poorly across most models. Proceed with caution.

Avoid

Score based on 3 of 5 models — moderate confidence

#1116out of 1127 in Health Care

Is STAAR SURGICAL CO a Good Investment in 2026?

STAAR SURGICAL CO (STAA) scores 1.3 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model is the most favorable, rating STAAR SURGICAL CO as Caution. However, the Graham model rates it Caution. STAAR SURGICAL CO currently trades above its estimated fair value of $13, suggesting limited upside at current prices. STAAR SURGICAL CO ranks #1116 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-16.1Market Cap958.6M

Estimated Fair Value

$13.1347% above

Trading above estimated fair value — the market may be pricing in future growth.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Caution

1/9

Buffett

Caution

Business quality & competitive moat

Graham

Caution

Price vs intrinsic value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is STAAR SURGICAL CO (STAA) a good investment?
Based on AlphaStocks' composite analysis, STAAR SURGICAL CO (STAA) scores 1.3 out of 10, earning a Avoid rating. This score is below average, suggesting caution. Trading above estimated fair value — the market may be pricing in future growth.
What is STAAR SURGICAL CO's Piotroski F-Score?
STAAR SURGICAL CO's Piotroski F-Score status is Caution. The raw score is 1/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is STAA overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $13, STAA appears overvalued. The stock currently trades 47% above its estimated fair value. Trading above estimated fair value — the market may be pricing in future growth.
How does STAA compare to other Health Care stocks?
STAAR SURGICAL CO ranks #1116 out of 1127 stocks in the Health Care sector, placing it in the top 99% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about STAA?
AlphaStocks evaluates STAA using five proven investment models. Piotroski: Caution; Buffett: Caution; Graham: Caution. These models are combined into a single composite score of 1.3/10.

Similar Stocks

Compare STAA with

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer